ciprofloxacin has been researched along with cefazolin in 95 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (5.26) | 18.7374 |
| 1990's | 20 (21.05) | 18.2507 |
| 2000's | 38 (40.00) | 29.6817 |
| 2010's | 23 (24.21) | 24.3611 |
| 2020's | 9 (9.47) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, FY; Chen, JH; Fung, CP; Lai, YK; Lin, CJ; Lin, JC; Ma, L; Siu, LK | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Grime, K; Paine, SW | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Callegan, MC; Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ | 2 |
| Adams, K; Calhoun, J; Cierny, G; Couch, L; Mader, JT | 1 |
| Fallara, A; Ravaoarinoro, M; Toma, E | 1 |
| Alveyn, CG; Lowes, JA; Robertson, DA; Tillotson, G; Wright, R | 1 |
| Bamberger, DM; Fields, MT; Herndon, BL | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
| Flint, NB; Tartaglione, TA | 1 |
| Boscia, JA; Kaye, D; Kobasa, WD | 1 |
| Bodner, E; Offer, C; Weuta, H | 1 |
| Guharoy, SR | 1 |
| Braga, B; Brazzoli, A; Depetri, G; Gazzotti, RM; Losio, R; Mileti, M; Usberti, M; Zucca, F | 1 |
| Kaiser, AB; Kernodle, DS | 1 |
| Abraham, OC; Brahmadathan, KN; George, S; Mathai, D; Peter, JV | 1 |
| Cohen, KL; Lauffenburger, MD | 1 |
| Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
| Abrams, DA; Katz, HR; Parks, DJ; Sarfarazi, FA | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Chen, YS; Cheng, DL; Liu, YC; Wang, JH; Wann, SR; Yen, MY | 1 |
| Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI | 1 |
| Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA | 1 |
| Allababidi, S; Shah, JC | 1 |
| Brownstein, S; Hill, VE; Jackson, WB; Mintsioulis, G | 1 |
| Finkelstein, F; Gorban-Brennan, N; Kliger, A; Troidle, L | 1 |
| Bolander, ME; Hanssen, AD; Huddleston, PM; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Bales, GT; Christiano, AP; Gerber, GS; Hollowell, CM; Kim, H; Kim, J; Patel, R | 1 |
| Dicker, AP; Figura, AT; Gomella, LG; Strup, SE; Valicenti, RK; Waterman, FM | 1 |
| Barnhill, MA; Hendrix, DV; Ward, DA | 1 |
| Rootman, DS; Suresh, PS | 1 |
| Banky, JP; Ostergaard, L; Spelman, D | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Baker, RJ; Brown, EA; Clemenger, M; Senior, H | 1 |
| Lee, KY; Lim, L | 1 |
| Bagia, JS; Hall, R | 1 |
| Kamat, AM; Lamm, DL | 1 |
| Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
| Ergör, G; Füzün, M; Hoşgörler, F; Kiliç, D; Terzi, C; Unek, T | 1 |
| Chatsuwan, T; Hiranrattana, A; Mekmullica, J; Pancharoen, C; Thisyakorn, U | 1 |
| Bonato, M; Dal Negro, G; Sciuscio, D; Vandin, L | 1 |
| Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
| Peterson, D; Schornack, MM | 1 |
| Sharma, N; Singhvi, A; Sinha, R; Tandon, R | 1 |
| Bukharin, OV; Chernikov, DA; Gritsenko, VA; Tret'iakov, AA | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Bouchard, CS; Bu, P; Carey, R; Riske, PS; Zaya, NE | 1 |
| Chaurasia, S; Das, S; Ramamurthy, B | 1 |
| Adelman, RA; Afshari, NA; Decroos, FC; Duncan, SM; Johnson, CS; Ma, JJ; Pineda, R; Starr, CE | 1 |
| Cliby, WA; Diehl, CL; El-Nashar, SA; Famuyide, AO; Stanhope, CR; Swanson, CL; Thompson, RL | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Cho, YH; Lee, G; Lee, SD; Shim, BS | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Fuentes, JM; Mullins, ME; Roe, JL | 1 |
| Pshenkina, NN | 1 |
| Akkaya, S; Bir, F; Kılıç, A; Nazalı, M | 1 |
| Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R | 1 |
| Chiu, SK; Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL; Yeh, KM | 1 |
| Ali, MH; Garg, P; Konda, N; Motukupally, SR; Sharma, S; Willcox, MD | 1 |
| Baum, CR; Thornton, MD | 1 |
| Coan, EB; Miller, KE | 1 |
| Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
| Bari, H; Khan, MR; Shariff, AH | 1 |
| Habeeb Rasool, K; Hammood Hussein, N; Mahamed Taha, B | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
| Kubickova, V; Santavy, P; Sima, M; Urbanek, K | 1 |
| Allen, L; Bartash, R; Cowman, K; Fauvel, D; Guo, Y; Minamoto, GY; Nnani, DU; Patel, S; Vukelic, S | 1 |
| Abdulla, A; Bos, K; de Winter, BCM; Koch, BCP; Muller, AE; Oosterhoff, M; van Oldenrijk, J; Zhao, Q | 1 |
| Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
| Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
| Craver, EC; Heckman, MG; Mohseni, M; Sheele, JM | 1 |
5 review(s) available for ciprofloxacin and cefazolin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Floxacillin; Humans; Immunocompetence; Male; Osteomyelitis; Penicillins; Recurrence; Salmonella; Salmonella Infections; Time Factors | 2002 |
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Ciprofloxacin; Humans; Linezolid; Microbial Sensitivity Tests; Vancomycin | 2022 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
8 trial(s) available for ciprofloxacin and cefazolin
| Article | Year |
|---|---|
Prevention of sepsis following endoscopic retrograde cholangiopancreatography.
Topics: Administration, Oral; Cefazolin; Cholangiopancreatography, Endoscopic Retrograde; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Risk Factors; Sepsis | 1991 |
Efficacy of perioperative prophylaxis with ciprofloxacin or cefazolin in colorectal surgery.
Topics: Adult; Cefazolin; Ciprofloxacin; Clinical Trials as Topic; Colon; Female; Humans; Male; Metronidazole; Premedication; Random Allocation; Rectum; Surgical Wound Infection | 1988 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefazolin; Cephalosporins; Child; Ciprofloxacin; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1996 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Cefazolin; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus; Treatment Outcome; Urticaria | 1998 |
Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cefazolin; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Treatment Outcome | 1999 |
Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Postoperative Complications; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections; Urologic Diseases | 2000 |
Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefazolin; Ciprofloxacin; Escherichia coli; Female; Hernia, Inguinal; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Surgical Procedures, Operative; Wounds and Injuries | 2005 |
82 other study(ies) available for ciprofloxacin and cefazolin
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Taiwan | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2016 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Topics: Animals; Cefazolin; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Cefazolin; Ciprofloxacin; Clindamycin; Diffusion; Dogs; Granulation Tissue; Methylmethacrylates; Ticarcillin; Tobramycin; Vancomycin | 1992 |
Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
Topics: beta-Lactamases; Cefazolin; Chloromercuribenzoates; Ciprofloxacin; Clavulanic Acids; Cloxacillin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Molecular Weight; Norfloxacin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry | 1992 |
Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.
Topics: Abscess; Animals; Cefazolin; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neutrophils; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus | 1991 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
Effect of imipenem-cilastatin and ciprofloxacin on tests for glycosuria.
Topics: Cefazolin; Cilastatin; Ciprofloxacin; Cyclopropanes; Drug Interactions; False Negative Reactions; Glycosuria; Humans; Imipenem; Quinolines; Thienamycins | 1985 |
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cefazolin; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Naphthyridines; Rabbits; Staphylococcal Infections | 1988 |
Serum sickness secondary to ciprofloxacin use.
Topics: Arthralgia; Cefazolin; Ciprofloxacin; Drug Hypersensitivity; Eosinophilia-Myalgia Syndrome; Female; Gentamicins; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Serum Sickness | 1994 |
Treatment of acute peritonitis by temporary discontinuation of dialysis and low doses of oral ciprofloxacin in patients on CAPD.
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Cefazolin; Ciprofloxacin; Clinical Protocols; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tobramycin | 1994 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; Staphylococcal Infections; Vancomycin; Wound Infection | 1994 |
Toxic strep syndrome.
Topics: Cefazolin; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefazolin; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies | 1993 |
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.
Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Arteriosclerosis; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Mortality; Penicillins; Retrospective Studies; Salmonella; Salmonella Infections; Seroepidemiologic Studies; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation.
Topics: Cefazolin; Ciprofloxacin; Drug Delivery Systems; Drug Implants; Gels; Glycerides; Solubility | 1998 |
Infectious keratopathy complicating photorefractive keratectomy.
Topics: Adult; Cefazolin; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratoplasty, Penetrating; Lasers, Excimer; Male; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Staphylococcal Infections; Staphylococcus aureus; Tropanes | 1998 |
Ciprofloxacin inhibition of experimental fracture healing.
Topics: Animals; Anti-Infective Agents; Biomechanical Phenomena; Cefazolin; Cephalosporins; Ciprofloxacin; Depression, Chemical; Drug Evaluation, Preclinical; Femoral Fractures; Femur; Fracture Healing; Male; Radiography; Rats; Rats, Wistar; Time Factors | 2000 |
Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Brachytherapy; Cefazolin; Cephalosporins; Ciprofloxacin; Cystoscopy; Drug Administration Routes; Humans; Male; Perineum; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Urinary Tract Infections | 2000 |
Effects of antibiotics on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cell Movement; Cephalosporins; Chloramphenicol; Ciprofloxacin; Cornea; Culture Techniques; Dogs; Epithelial Cells; Gentamicins; Statistics, Nonparametric; Tobramycin | 2001 |
Bilateral infectious keratitis after a laser in situ keratomileusis enhancement procedure.
Topics: Adult; Cefazolin; Ciprofloxacin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Keratitis; Keratomileusis, Laser In Situ; Staphylococcal Infections; Staphylococcus aureus | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Empirical aminoglycosides for peritonitis do not affect residual renal function.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Creatinine; Drug Administration Schedule; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Practice Guidelines as Topic; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Urea | 2003 |
Pseudomonas keratitis associated with continuous wear silicone-hydrogel soft contact lens: a case report.
Topics: Adult; Cefazolin; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Silicone Elastomers | 2003 |
Extracranial mycotic carotid pseudoaneurysm.
Topics: Aneurysm, False; Aneurysm, Infected; Anti-Infective Agents; Carotid Artery Diseases; Carotid Artery, Common; Cefazolin; Ciprofloxacin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Radiography; Sepsis; Treatment Outcome; Urinary Tract Infections; Vascular Surgical Procedures | 2003 |
Antitumor activity of common antibiotics against superficial bladder cancer.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cefazolin; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Genes, p53; Humans; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder Neoplasms | 2004 |
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996-2000).
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Infective Agents; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Feces; Female; Hospitalization; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Shigella; Thailand; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system.
Topics: Animals; Cefazolin; Cefotaxime; Ciprofloxacin; Colony-Forming Units Assay; Doxorubicin; Granulocytes; Hematopoietic Stem Cells; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Valproic Acid; Zidovudine | 2006 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Staphylococcus aureus ulcer associated with continuous wear of silicone hydrogel contact lenses.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gentamicins; Humans; Hydrogels; Male; Prosthesis-Related Infections; Silicones; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Pseudomonas keratitis after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalosporin Resistance; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Kanamycin Resistance; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Postoperative Complications; Pseudomonas Infections; Tobramycin | 2006 |
[Taxonomic spectrum and antibiotic resistance of Enterobacteriaceae isolated from bile of patients with cholangitis].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bile; Cefazolin; Cefotaxime; Cholangitis; Chronic Disease; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Gentamicins; Humans; Male; Middle Aged | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Chlorhexidine; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2007 |
Microbial keratitis in a case of lamellar ichthyosis.
Topics: Anti-Bacterial Agents; Cefazolin; Child; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Ectropion; Eye Infections, Bacterial; Humans; Ichthyosis, Lamellar; Male; Proteus; Proteus Infections; Staphylococcal Infections; Staphylococcus | 2008 |
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Retrospective Studies | 2008 |
Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Ciprofloxacin; Cohort Studies; Drainage; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Obesity, Morbid; Ofloxacin; Retrospective Studies; Subcutaneous Fat, Abdominal; Surgical Wound Infection | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.
Topics: Acute Disease; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
Underdosing of common antibiotics for obese patients in the ED.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Cefazolin; Cefepime; Cephalosporins; Ciprofloxacin; Emergency Service, Hospital; Humans; Obesity; Retrospective Studies | 2012 |
[Influence of perftoran on pharmacokinetics of hydrophilic drugs].
Topics: Animals; Blood Substitutes; Cefazolin; Cefotaxime; Ciprofloxacin; Drug Interactions; Fluorocarbons; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Male; Pentoxifylline; Rabbits | 2011 |
Cefazolin-sodium has no adverse effect on fracture healing in an experimental rabbit model.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Bone Density Conservation Agents; Bony Callus; Casts, Surgical; Cefazolin; Ciprofloxacin; Fibula; Fracture Healing; Fractures, Closed; Male; Models, Animal; Rabbits; Radiography; Random Allocation; Tibial Fractures; Vitamin D; Vitamin E | 2012 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Eye; Female; Humans; Infant; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Sulbactam; Young Adult | 2013 |
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2013 |
Microbial analyses of contact lens-associated microbial keratitis.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefazolin; Ciprofloxacin; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Male; Retrospective Studies; Risk Factors; Young Adult | 2014 |
A seashell by the seashore.
Topics: Animal Shells; Animals; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Child; Ciprofloxacin; Foreign Bodies; Heel; Humans; Lacerations; Male; Radiography | 2015 |
Penetrating Orbital Injury From a Needlefish.
Topics: Adult; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Beloniformes; Cefazolin; Ciprofloxacin; Diplopia; Diving; Fluoroquinolones; Foreign Bodies; Humans; Male; Military Personnel; Moxifloxacin; Prednisone; Prefrontal Cortex; Tomography, X-Ray Computed; Wounds, Penetrating | 2016 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Antibiotics in acute calculous cholecystitis - do Tokyo guidelines influence the surgeons' practices?
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cholecystectomy; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Ciprofloxacin; Conversion to Open Surgery; Drug Therapy, Combination; Female; Gallstones; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Pakistan; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Surgeons; Surgical Wound Infection; Treatment Outcome | 2017 |
Molecular Detection of
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cefepime; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Inhibitory Concentration 50; Iraq; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Salmonella typhi; Tobramycin; Typhoid Fever | 2020 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Population pharmacokinetics of three alternative prophylactic antibiotics during cardiac surgery with extracorporeal circulation.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefazolin; Ciprofloxacin; Extracorporeal Circulation; Humans; Prospective Studies | 2023 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Rifampin; Treatment Outcome; Vancomycin | 2022 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Can Urinalysis and Past Medical History of Kidney Stones Predict Urine Antibiotic Resistance?
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Kidney Calculi; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis; Urinary Tract Infections | 2022 |